Ebn Sina
EXFORGE HCT 10/160/12.5 MG TAB 28S
QAR 157.00
Title
QAR 157.00
Exforge HCT is indicated ONLY as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a ...